Cytokine and Chemokine Levels in Serum and Tears As Disease Activity Biomarkers in Patients with Primary Sjogren's Syndrome

被引:0
|
作者
Alejandro Castillo-Ortiz, Angel [1 ]
Elda Barbosa-Cobos, Rosa [2 ]
Becerril-Mendoza, Lizbeth [3 ]
Lugo-Zamudio, Gustavo [3 ]
Lima-Gomez, Virgilio [3 ]
Moreno-Eutimio, Adan [3 ]
Nieto-Velazquez, Nayeli [3 ]
Tzec-Perez, Angel [3 ]
机构
[1] Hosp Juarez Mexico, Rheumatol, Merida, Mexico
[2] Hosp Juarez Mexico, Rheumatol, Mexico City, DF, Mexico
[3] Hosp Juarez Mexico, Mexico City, DF, Mexico
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
663
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Faecal Levels of Calprotectin Are Increased in Patients with Primary Sjogren's Syndrome and Correlates with Disease Activity
    Mandl, Thomas
    Ohlsson, Bodil
    Andreasson, Kristofer
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [22] Prednisolon Reduce Cytokine but Increase Autoantibody Levels in Patients with Primary Sjogren's Syndrome
    Reksten, Tove Ragna
    Jonsson, Roland
    Brokstad, Karl Albert
    Jonsson, Malin
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 71 (06) : 491 - 491
  • [23] Smoking, disease characteristics and serum cytokine levels in patients with primary Sjögren’s syndrome
    Peter Olsson
    Kristin Skogstrand
    Anna Nilsson
    Carl Turesson
    Lennart T. H. Jacobsson
    Elke Theander
    Gunnar Houen
    Thomas Mandl
    Rheumatology International, 2018, 38 : 1503 - 1510
  • [24] VITAMIN D LEVELS AND THE CORRELATION WITH DISEASE ACTIVITY IN PRIMARY SJOGREN'S SYNDROME
    Yilmaz, Z.
    Karabulut, G.
    Kitapcioglu, G.
    Kabasakal, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 909 - 909
  • [25] Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjogren's syndrome
    Moriyama, M.
    Hayashida, J-N.
    Toyoshima, T.
    Ohyama, Y.
    Shinozaki, S.
    Tanaka, A.
    Maehara, T.
    Nakamura, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 169 (01): : 17 - 26
  • [26] Chemokine expression in primary Sjogren's syndrome
    Wakefield, D
    Palladinetti, P
    Tedla, N
    Di Girolamo, N
    Lloyd, AR
    McCluskey, PJ
    Cuello, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S553 - S553
  • [27] Biomarkers for Primary Sjogren's Syndrome
    Chen, Weiqian
    Cao, Heng
    Lin, Jin
    Olsen, Nancy
    Zheng, Song Guo
    GENOMICS PROTEOMICS & BIOINFORMATICS, 2015, 13 (04) : 219 - 223
  • [28] Serum transthyretin levels and disease activity in patients with primary Sjögren's syndrome
    Peng, You-Fan
    Lu, Fei-Yan
    Deng, Yi-Bin
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2024, 16
  • [29] SERUM AUTOANTIBODY PROFILING OF PRIMARY SJOGREN'S SYNDROME PATIENTS REVEALS NOVEL BIOMARKERS ASSOCIATED WITH THE DISEASE, DISEASE ACTIVITY, AND CLINICAL RESPONSE TO VAY736
    Budde, P.
    Doucet, J.
    Zucht, H. -D.
    Kazma, R.
    Maguire, P.
    Avrameas, A.
    Valentin, M. -A.
    Oliver, S.
    Schulz-Knappe, P.
    Vitaliti, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 886 - 886
  • [30] CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjogren's Syndrome
    Nocturne, G.
    Seror, R.
    Fogel, O.
    Belkhir, R.
    Boudaoud, S.
    Saraux, A.
    Larroche, C.
    Le Guern, V.
    Gottenberg, J. E.
    Mariette, X.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (12) : 3226 - 3233